Q1 2027 Mastek Ltd Earnings Call Transcript
Key Points
- Mastek Ltd (BOM:523704) reported a strong order book performance with a 25% year-on-year growth in their 12-month order backlog.
- The company achieved a 5% quarter-on-quarter revenue growth in INR terms and a 1.8% growth in constant currency terms.
- The UK business remains a strong foundation, growing by 3% quarter-on-quarter in constant currency terms.
- North America saw a strong order book performance for the third consecutive quarter, highlighted by a $25 million AI transformation deal.
- Mastek Ltd (BOM:523704) is positioning itself as an AI transformation company, leveraging its Enterprise Application Transformation business and strong data practice.
- The Middle East business is facing severe headwinds due to geopolitical instability, impacting predictability and performance.
- There was a decline in revenue from the top 5 clients, attributed to a timing gap in project transitions within the health care sector.
- Subcontractor costs remain high, accounting for 18.5% of total revenue, which could impact margins.
- The company anticipates an impact on EBITDA margins due to ESOP costs, estimated at $400,000 to $500,000 per quarter.
- Political changes in the UK could affect the public sector business, requiring close monitoring of policy and budget changes.
Ladies and gentlemen, good day, and welcome to Mastek Limited Q1 and FY27 earnings conference call.
This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinion and expectation of the company as on date of this call. These statements are not a guarantee of future performance and involve risk and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference has been recorded.
I now hand the conference over to Mr. Pratik Jagtap from E&Y Investor Relations. Thank you, and over to you, sir.
Thank you, Ganesh. Good afternoon to all of you, and welcome to Q1 FY27 earnings call of Mastek. The results and presentation have already been mailed to you, and you can also view it on our website, www.mastek.com.
To take us through the results today and to answer your questions, we have the top management of Mastek represented by Umang
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
